Breast cancer stage at time of detection in women with systemic lupus erythematosus

Lupus

Volumn 13, Issue 6, 2004, Pages 469-472

  Bernatsky, S ^a,e   Clarke, A ^a   Ramsey Goldman, R ^b   Boivin, J F ^c   Joseph, L ^a,c   Rajan, Raghu ^a   Manzi, S ^d  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e NONE   (Canada)

Author keywords

Cancer stage; Detection bias; Malignancy; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS; SEER PROGRAM;

EID: 3142694073     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1008xx     Document Type: Article

References (18)

1. Bernatsky S, Clarke A, Ramsey-Goldman R. Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep 2002; 4: 351-58.
2. Bjornadal L, Lofstrom B, Yin L, Lundberg I, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 66-71.
3. Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 761-68.
4. Ramsey-Goldman R, Clarke A. Double trouble: Are lupus and malignancy associated? Lupus 2001; 10: 388-91.
5. Wells C, Peduzzi P, Feinstein A. Presenting manifestations, cigarette smoking, and detection bias in age at diagnosis of lung cancer. Ann Epidemiol 2001; 11: 239-47.
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271-77.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1998; 41: 751.
8. Newcombe R. Interval estimation for the difference between independent proportions: Comparison of eleven methods. Statistics Med 1998; 17: 873-90.
9. Wilson E. Probable inference, the law of succession, and statistical inference. J Am Statist Assoc 1927; 22: 209-11.
10. Ramsey-Goldman R, Mattai SA, Schilling E, Chiu Y-L, Alo CJ, Howe HL. Increased risk of malignancy in patients with systemic lupus erythematosus. J Investig Med 1998; 46: 217-22.
11. Henson D, Chu K, Levine P. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women. Cancer 2003; 98: 908-17.
12. Hughes G. Lupus patients are protected from cancer. Lupus 2002; 10: 833-34.
13. Bernatsky S, Ramsey-Goldman R, Boivin J, Joseph L, Rajan R, Zoma A. Cancer in systemic lupus erythematosus (SLE): An international multicentre cohort study. Arthritis Rheum 2003; 48(9S): (abstract S1820).
14. Bernatsky S, Boivin J, Joseph L et al. The prevalence of factors influencing cancer risk in lupus: Social habits, reproductive issues, and obesity. J Rheumatol 2002; 29: 2551-54.
15. Bernatsky S, Ramsey-Goldman R, Boivin J-F et al. Do traditional Gail model risk factors account for increased breast cancer in women with lupus? J Rheumatol 2003; 30: 1505-507.
16. Bernatsky S, Clarke A, Gordon C et al. Does breast cancer risk in SLE differ according to history of hormone replacement therapy exposure when other reproductive factors are accounted for? Arthritis Rheum 2003; 46(9S): (abstract S402).
17. Liu ZH, Cheng ZH, Gong RJ, Liu H, Liu D, Li LS. Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese. Nephron 2002; 90: 174-80.
18. Lahita R. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11: 352-56.